Cambridge, MA, United States of America

Krishna K Murthi

This inventor holds 17 USPTO granted patents and 7 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: The Florida State University Research Foundation, Inc., Agennix USA Inc., Gpc Biotech, Inc.. Active years: 1995-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Krishna K Murthi. Retrieved from https://idiyas.com/inventor/krishna-k-murthi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 17 

% Patents Active = 47.1



Average Co-Inventor Count = 6.3

ph-index = 7

Forward Citations = 120(Granted Patents)


Location History:

  • Tallahassee, FL (US) (1995)
  • Charlottesville, VA (US) (1997 - 2002)
  • Waltham, MA (US) (2002)
  • Cambridge, MA (US) (2004 - 2011)
  • Andover, MA (US) (2012 - 2013)

Company Filing History:


Years Active: 1995-2013

Loading Chart...
Loading Chart...
Loading Chart...
17 patents (USPTO):Explore Patents

Title: The Innovative Mind of Krishna K Murthi

Introduction

Krishna K Murthi, based in Cambridge, MA, is a prominent inventor known for his significant contributions to the field of pharmaceuticals and innovative compounds. With an impressive portfolio of 17 patents, he has focused on developing treatments that have the potential to combat serious diseases such as cancer.

Latest Patents

Among his latest inventions are two notable patents that showcase his dedication to medical advancements. The first patent is centered around Pyrido [2,3-D] pyrimidines and their use as kinase inhibitors. This invention provides derivatives of pyrido[2,3-d]pyrimidin-7-one, which are identified as kinase inhibitors that display anti-proliferative activity against tumor cells. These compounds hold promise as therapeutic options for treating cancer.

The second patent involves derivatives of squaric acid exhibiting anti-proliferative activity. This invention details compounds such as derivatives of 3,4-diamino-cyclobut-3-ene-1,2-dione, showcasing their utility in medicine, particularly in combating diseases like cancer. These derivatives can exist as single stereoisomers or mixtures thereof, providing flexibility in their pharmaceutical applications.

Career Highlights

Murthi has made his mark in various esteemed institutions, contributing significantly to research and development. He has worked with Florida State University and GPC Biotech, Inc., where he applied his expertise to advance the field of therapeutic innovations. His work in these organizations has allowed him to bridge the gap between research and practical medical solutions.

Collaborations

Throughout his career, Krishna K Murthi has collaborated with notable colleagues, including Robert A. Holton and Carmen Somoza. These collaborations have further enriched his research and innovation endeavors, leading to breakthroughs in the development of therapeutic compounds.

Conclusion

Krishna K Murthi exemplifies the spirit of innovation in the medical field. With his 17 patents, including groundbreaking work on kinase inhibitors and anti-proliferative compounds, he continues to inspire the next generation of inventors and researchers. His dedication to improving healthcare through innovative inventions is a testament to the importance of creativity in scientific advancement.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…